New research illustrates the importance of monitoring patients over the long term after melanoma is diagnosed. Data on more than 4,700 patients revealed melanoma recurrence rates of close to 7% at 15 years and 11% at 25 years after initial treatment. However, the researchers reported that those who experienced recurrence 10 or more years after treatment were about 40% less likely to die of the disease than those whose melanoma recurred within three years. The results appear in the Journal of the American College of Surgeons.
Published in Brief: